Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differentia
about
Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis.Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients.Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer.The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers.Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tuTicagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.Harnessing the immune system in the battle against breast cancer.Expression of NK Cell Surface Receptors in Breast Cancer Tissue as Predictors of Resistance to Antineoplastic Treatment.Low baseline levels of NK cells may predict a positive response to ipilimumab in melanoma therapy.Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.Lymphocyte subsets predictive value and possible involvement of human papilloma virus infection on breast cancer molecular subtypes
P2860
Q36114808-ED9DACA6-3B85-4C10-AC43-FAD9F7D90214Q37222064-B6A44A21-259C-4548-A4CD-9A506B275F6BQ37335249-55F7CBB3-E86B-4A95-A2C4-8F69847DECD6Q41620122-CDD18F02-671B-4A7C-91A1-F22672CAA4B6Q48121626-7710D5E0-23BB-4B95-B546-8D14B3DCE435Q48265369-F0F612E3-446E-448B-B069-1D98C159B3E3Q49884762-16B5E6D2-03C0-40BF-B0CB-AB0D48955041Q52725437-A6C967FE-3572-4796-86A4-E7E24EE68870Q53772695-A15B41FD-3890-44F4-8F0F-21DF76C5F2DAQ55447685-7DBE40D9-02FE-4425-B217-E2D40935B045Q58690952-BD03A894-B37C-4BC7-8577-6FC98BE646DC
P2860
Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differentia
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Natural killer (NK) cell profi ...... hemotherapy (NAC): differentia
@ast
Natural killer (NK) cell profi ...... hemotherapy (NAC): differentia
@en
type
label
Natural killer (NK) cell profi ...... hemotherapy (NAC): differentia
@ast
Natural killer (NK) cell profi ...... hemotherapy (NAC): differentia
@en
prefLabel
Natural killer (NK) cell profi ...... hemotherapy (NAC): differentia
@ast
Natural killer (NK) cell profi ...... hemotherapy (NAC): differentia
@en
P2093
P2860
P1476
Natural killer (NK) cell profi ...... hemotherapy (NAC): differentia
@en
P2093
Chandan Verma
Gerard P Cowley
Jennifer M Eremin
Mohamed A El-Sheemy
Mohammad Ilyas
Oleg Eremin
Viriya Kaewkangsadan
P2860
P2888
P356
10.1186/S12967-015-0535-8
P577
2015-06-04T00:00:00Z
P5875
P6179
1000959769